Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells (Q40243680)

18 September 2017

Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells (English)

1 reference

18 September 2017

1 reference

2

1 reference

18 September 2017

5

1 reference

18 September 2017

A Y Olsson

1

1 reference

18 September 2017

S Edwards

3

1 reference

18 September 2017

R Te Poele

4

1 reference

18 September 2017

S Merson

6

1 reference

18 September 2017

C S Cooper

7

1 reference

18 September 2017

language of work or name

English

0 references

publication date

14 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

26

1 reference

18 September 2017

7

1 reference

18 September 2017

1028-1037

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209854

18 September 2017

0 references

cites work

Molecular alterations in primary prostate cancer after androgen ablation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Distinctions in the specificity of E2F function revealed by gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Analysis of gene function in somatic mammalian cells using small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Amplification and overexpression of E2F3 in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Current status of the molecular genetics of human prostatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

What we could do now: molecular pathology of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

A molecular signature of metastasis in primary solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

A rapid and convenient method for isolation of nuclear, cytoplasmic and total cellular RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

The E2F1-3 transcription factors are essential for cellular proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Conditional deletion of Rb causes early stage prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Chromosomal imbalances in small cell carcinomas of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209854

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference